“This event was great! Super helpful in understanding how other organizations manage IITs.” -Project Manager, OTSUKA
“All sessions were great, with very informative topics.” -Associate Director, External Grants, ALKERMES
Investigator Initiated Trials are a complex but critical part of the drug development process. Your teams may encounter controversies related to legal compliance and the ownership of raw data and IP.
The 3rd Investigator Initiated Trials Summit focuses on creating a bridge between pharma suppliers and their institutional counterparts who are providing vital data and real-world evidence. Join us November 13-14 in Philadelphia to get the crucial training your teams need to improve communication and compliance.
Gain All-New Insights On:
- Combine Resources to Help Even the Smallest Patients Populations
- Compare and Contrast Collaborative Studies vs. Traditional IITs/IIRs
- Building and Maintaining the Best Teams
- Addressing the Role of the MSL in IITs
- Proper Contract and Budgetary Negotiations
- Best Practices for Collaborating with a Site or Institution
- Value and Security of Well-Trained Admins
- Investigator Initiated Trials
- Chief Risk and Compliance Officers
- Collaborative Research
- Scientific Communications
- Medical Affairs
- MSLs
- External Research, Partnerships and Collaborations
- Clinical Research, Clinical Operations Clinical Specialists, Clinical Trial Monitoring Clinical Outcomes and Publications
- Medical Research and Medical Writing
- Scientific Research and Management
- Medical Scientist
- Medical Operations
- Grants
- Contract Management
- Health Economics and Outcomes Research
- Trials Managers
- Congress Operations
- Research Process and Infrastructure
- External Research
- Data Transparency
- Global IST Operations
- MA Study and ISR Operations
- Site Management
- Pre-Market Studies
- Post-Market Studies
- Corporate Funding
Stay up to date on the latest announcements